Clinical trial
The Effect of Sodium Pyruvate Nasal Spray on Coughing in Patients With Idiopathic Pulmonary Fibrosis
NCT06037408 is registered in ClinicalTrials.gov with Cellular Sciences, inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Sodium Pyruvate Nasal Spray on Coughing in Patients With Idiopathic Pulmonary Fibrosis
- Lead sponsor
- Cellular Sciences, inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- August 15, 2023
- Completion date
- May 20, 2024
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.